Sofinnova Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-157,172
| Closed | -$3.35M | – | 83 |
|
|
2024
Q1 | $3.35M | Buy |
157,172
+31,873
| +25% | +$680K | 0.19% | 49 |
|
|
2023
Q4 | $1.2M | Buy |
125,299
+8,200
| +7% | +$78.8K | 0.07% | 48 |
|
|
2023
Q3 | $304K | Hold |
117,099
| – | – | 0.02% | 49 |
|
|
2023
Q2 | $547K | Hold |
117,099
| – | – | 0.04% | 43 |
|
|
2023
Q1 | $441K | Hold |
117,099
| – | – | 0.03% | 47 |
|
|
2022
Q4 | $369K | Hold |
117,099
| – | – | 0.02% | 46 |
|
|
2022
Q3 | $352K | Buy |
117,099
+39,033
| +50% | +$117K | 0.02% | 51 |
|
|
2022
Q2 | $194K | Hold |
78,066
| – | – | 0.02% | 52 |
|
|
2022
Q1 | $607K | Hold |
78,066
| – | – | 0.05% | 50 |
|
|
2021
Q4 | $326K | Hold |
78,066
| – | – | 0.02% | 59 |
|
|
2021
Q3 | $618K | Buy |
+78,066
| New | +$618K | 0.04% | 60 |
|